US hearts bleed for slain Indian; Crowdfunding helps raise Rs 2cr

February 25, 2017

Washington, Feb 25: In an ideal world, an America of their dreams, they might have forged a start-up company called Kuchibhotla & Madasani. But a hateful moment in the American hinterland, spotty with prejudice, extinguished their dreams.techie

Srinivas Kuchibhotla and Alok Reddy Madasani conformed to the archetype Indian nerds taking a familiar route to the US. Finish undergrad engineering in India, go to US for Master's, and latch on to a job here through the OPT (Optional Practical Training) and H1-B visa route. Over the past decade, a majority of such IT professionals are from Andhra/Telengana region because of the proliferation of engineering colleges there.

Kuchibhotla, who went by the nickname Srinu, studied electrical engineering at the Vidya Jyothi Institute of Technology in Hyderabad before coming to US to earn a master's degree in electrical and electronic engineering from the University of Texas at El Paso, where he also worked as a teaching and research assistant before graduating in 2007. He began as a software engineer at Rockwell Collins and worked there until 2014, when he moved to Kansas to start a job at Garmin International.

Madasani, who was an aviation program coordinator manager at Garmin, had a similar background. He studied at the Vasavi College of Engineering, also in Hyderabad, before coming to the University of Missouri-Kansas City for his Master's. A cricket buff, he has a 2013 photo of Sachin Tendulkar as his cover photo on Facebook.

The two were regulars at the Austin Bar and Grill, where waiters told the local media they came couple of times a week to drink Jameson's and smoke over a basketball game.

Also a regular patron is Ian Grillot, the American who tackled the gunman at the first opportunity, believing he had emptied the magazine, but found his shoulder intercepting the last bullet.

''It wasn't right, and I didn't want the gentleman (the gunman) to potentially go after somebody else,'' Grillot said in a video released by the University of Kansas Health System, amid all-round praise for standing up for American values. He was ''just doing what anyone should have done.''

''It's not about where he's from, or ethnicity. We're all humans,'' he told the local media of the life he had saved, calling the survivor Madasani his ''best friend'' now.

Olathe residents, and Americans and Indians across the country, spoke from their hearts -- and their wallets as the incident ignited passionate discussions on social media. A funding campaign to help Kuchibhotla's family by aiming to raise $ 150,000 raced towards $ 300,000 within 24 hours of going up.

Among those who wrote on the site was Grillot's sister Maggie, who said, ''My brother was the third victim. My deepest condolences to the family- I'm so very sorry for your loss. My brother wishes he could have done more for your family. Keeping everyone in my prayers.''

Another message read: ''As a former engineer myself who has worked with many very friendly and hard working Indian engineers over the years I can't help but feel so badly for this man and his family... I'm horrified at this shooter's racism since I have never met an Indian native that I didn't like. Praying for Srini and his family.''

Indian consular officials are helping the victims' family and other Indian professionals come to grips with the situation.

But for Srinu's wife Sunayana, it is a tragedy beyond grief. ''Thanks for all those who made it to farewell parties!!!!! It was very difficult and emotional moment to leave you all, to start our new journey at Kansas,'' she had posted on social media in 2014 as they left Dallas.

One of her last posts from Kansas read, ''Totally enjoyed Hasee toh phasee -- a good movie after a long time.''

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Beijing, Mar 25: Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Y UDAYA CHANDAR
 - 
Monday, 13 Apr 2020

Dear Sir,

 

I am 77 but a very healthy person with remarkable immunity. I contracted Malaria fever in 1994 because of mosquito biting and I have not been sick anytime there after, not even for ordinary fever in the last 26 years.

 

I am sure you would like to conduct the trials on persons of varying criteria. I am sure you don't want to carry out the trials on perfectly healthy young individuals only. 

 

I am certain that  you want to try the vaccine on a 'common man' from 'general public.' I am ready for the trial and you can take me. I will be delighted. 

 

If you are not handling this matter kindly forward this mail to the correct agency.

 

I look forward to hearing from you.

 

Best regards.

 

If you are not moving forward, you are really moving backward.

Y Udaya Chandar

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 24,2020

Jun 24: The coronavirus tally in Pakistan reached 188,926 with the detection of 3,892 new cases in the last 24 hours, the health ministry said on Wednesday.

Sixty more people died due to the viral infection, taking the death toll to 3,755.

As many as 3,337 patients are in critical condition across the country, the ministry said.

With the detection of 3,892 new cases in the last 24 hours, the coronavirus tally in the country now stands at 188,926, it said.

Sindh reported the maximum number of 72,656 cases, followed by 69,536 in Punjab, 23,388 in Khyber-Pakhtunkhwa, 11,483 in Islamabad, 9,634 in Balochistan, 1,337 in Gilgit-Baltistan and 892 in Pakistan-occupied Kashmir (Pok).

Health authorities have so far conducted 1,150,141 coronavirus tests, including 23,380 in the last 24 hours.

A total of 77,754 patients have recovered so far from the disease.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 24,2020

Kathmandu, Jul 24: At least 132 people lost their lives as a result of heavy rains triggering landslides, and flash floods in Nepal.

"132 people dead, 128 injured, 53 missing and 998 families affected due to rainfall, landslides and floods in the country as of 23rd July," Nepal Disaster Risk Reduction and Management Authority Within the last two weeks, the Myagdi district of western Nepal was the worst affected with 27 reported deaths.

Search and rescue operations are being conducted continuously with officials and police personnel who are looking through the debris to find missing people.

Monsoon-induced disasters are common in Nepal owing to the country's mountainous topography. Hundreds have been displaced as landslides have swept away their homes. They ended up taking refuge in local schools and community centers.

Nepal's Meteorological Forecasting Division earlier last week had predicted heavy downpour across the country. The Division had warned of monsoon winds being near the low-pressure line in the Terai belt, which would consequently cause more rainfall.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.